scholarly article | Q13442814 |
P356 | DOI | 10.3109/03009747709095458 |
P698 | PubMed publication ID | 607393 |
P2093 | author name string | Isomäki H | |
Koota K | |||
Mutru O | |||
P2860 | cites work | Aspirin-induced depression of renal function | Q28330550 |
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. | Q33626235 | ||
Death Rate and Causes of Death in Patients with Rheumatoid Arthritis | Q42139986 | ||
P433 | issue | 4 | |
P304 | page(s) | 241-244 | |
P577 | publication date | 1977-01-01 | |
P1433 | published in | Scandinavian Journal of Rheumatology | Q15767622 |
P1476 | title | Death rate and causes of death in RA patients during a period of five years | |
P478 | volume | 6 |
Q35609808 | Abnormal directed migration of blood polymorphonuclear leukocytes in rheumatoid arthritis. Potential role in increased susceptibility to bacterial infections |
Q41717882 | Anesthesia on the rheumatoid patient |
Q33552918 | Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis |
Q52871509 | Death certificate and mortality in rheumatoid arthritis. |
Q58422026 | Do men have more severe psoriasis than women? |
Q34986307 | Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. |
Q40182246 | Further studies on serum lipoproteins in connective tissue diseases |
Q35610718 | Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice |
Q24796769 | Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis |
Q44204294 | Increased Mortality Among Persons with Rheumatoid Arthritis, But Where RA Does Not Appear on Death Certificate:Eleven-Year Follow-Up of an Epidemiological Study |
Q36691113 | Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review |
Q38079456 | Inflammation and rheumatoid arthritis |
Q39835948 | Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs |
Q41913707 | Long-term outcome of treating rheumatoid arthritis: results after 20 years |
Q33567099 | Microalbuminuria in patients with rheumatoid arthritis |
Q33556875 | Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis |
Q35551023 | Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis |
Q74705799 | Outcomes for patients undergoing one or more total hip and knee arthroplasties |
Q77124527 | Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response |
Q37301130 | Rheumatoid arthritis-associated interstitial lung disease |
Q43315904 | Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis |
Q34485318 | Ten year mortality and causes of death in patients with rheumatoid arthritis |
Q72569860 | The economic impact of musculoskeletal disorders |
Q70426602 | The long-term effects of treating rheumatoid arthritis |
Q37717307 | The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis |
Q69549268 | Urine- and serum beta 2-microglobulin in patients with rheumatoid arthritis: a study of 101 patients without signs of kidney disease |
Q39609243 | What happens to patients with rheumatoid arthritis? The long-term outcome of treatment |
Search more.